Genscript Biotech
1548.HK
₹161.61
Share price
2.07%
Change (1 day)
76.23%
Change (1 year)
Categories
Genscript Biotech (1548.HK) - Cash on Hand
Cash on Hand as of December 2024 : ₹53.24 Billion
According to Genscript Biotech
's latest financial reports the company has ₹53.24 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Genscript Biotech - Cash on Hand chart (from 2015 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | ₹160.50 B | 32.55% |
| 2022-12-31 | ₹121.09 B | 15.94% |
| 2021-12-31 | ₹104.44 B | 85.19% |
| 2020-12-31 | ₹56.39 B | 85.43% |
| 2019-12-31 | ₹30.41 B | -22.96% |
| 2018-12-31 | ₹39.47 B | 387.06% |
| 2017-12-31 | ₹8.10 B | -12.59% |
| 2016-12-31 | ₹9.27 B | 34.54% |
| 2015-12-31 | ₹6.89 B | 286.16% |
| 2014-12-31 | ₹1.78 B |